The global market for computational biology is expected to reach USD
4,285.1 million by 2020 growing at a CAGR of 21.1%. Steady increase in the
usage & application of computational biology for bioinformatics R&D
programs designed for sequencing genomes to better understand biological
systems and increasing number of clinical studies in pharmacogenomics and
pharmacokinetics for novel drug discovery studies are expected to drive
computational biology demand over the next six years.
Computational genomics for cellular and biological simulation
applications dominated the market in 2013, accounting for over 47% of global
revenue. Key factors driving demand for these applications include the growth
of drug designing, disease modeling and personalized medicine applications and
the growing usage of computational biology for functional and structural
genomics, epigenomics and metagenomics for the analysis of protein
transcription, protein-protein interactions, gene sequencing and expression and
3-dimensional protein structure analysis.
Browse Detail Report With TOC @ http://www.hexareports.com/report/computational-biology-market/
Further key findings from
the study suggest:
North America was the largest regional market, accounting for 58.0% of
the global revenue in 2013. Its large share is majorly attributed to the
growing research investments and initiatives for development of drug discovery,
disease modeling technologies and innovations in biological computation
methods. It is expected that Asia Pacific will witness the fastest growth in
the market, at an estimated CAGR of 28.0% owing to the increasing expenditure
in clinical studies for pharmacokinetics and pharmacogenomics.
The application of computational biology in proteomics for cellular
simulation is expected to grow at the fastest CAGR of over 22% owing to the
shift in sequencing studies towards further analysis of the nature of various
biological proteins as a part of development of personalized medicine.
Drug discovery and disease modelling applications dominated the market,
accounting for 58.0% of global revenue in 2013. This large share is attributed
by the extensive drug development pipelines present for a number of global
branded and generic drug manufacturing firms such as Sanofi, Novo Nordisk and Eli
Lilly.
Request A Sample copy of This Report @ http://www.hexareports.com/sample/42483
Computational Biology databases dominated the tools segment and accounted
for 44.5% of the market revenue in 2013, owing to extensive genomic database
usage for warehousing and data mining of biological and sequential data
generated from genomic and proteomic studies. Consequentially, the software and
services for the analysis of biological data is expected to witness the fastest
CAGR of over 21.0%.
Key players of this market include Schrodinger, Accelrys, Certara,
Entelos, Simulation Plus and others.
Browse Full Report @ http://www.hexareports.com/report/computational-biology-market/
About Us:
Hexa Reports is a market
research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe.
We offer comprehensive business intelligence in the form of industry reports
which help our clients obtain clarity about their business environment and
enable them to undertake strategic growth initiatives.
Contact
Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Our Website: http://www.hexareports.com/
Our Blog: http://deepresearch2015.blogspot.in/
